People who develop MS begin using healthcare services more frequently up to 15 years before their MS symptoms first appear.

Better physical performance is associated with higher cognitive function in people with MS, particularly in those with ...

Enrollment is complete for a Phase 2 trial testing Zenas Biopharma's obexelimab in relapsing MS, with results expected later ...

The experimental CAR T-cell therapy treatment was given as part of a clinical trial that's enrolling adults with progressive ...

Beneficiaries of plans that covered fewer than the median number of DMTs in the past year were more likely to have a relapse, ...

Columnist Desiree Lama has had to find some self-care strategies for managing her MS while also staying atop her work as a ...

Quantum signed a manufacturing agreement for the production of Lucid-MS as it prepares for a Phase 2 trial of the ...

Guest writer Donald Kushner, MD, reflects on the similarities between the main character in a classic film and living with MS.

Donald Kushner, MD, is a retired physician, board certified in internal medicine and hospice and palliative care. He has lived with multiple sclerosis (MS) for more than 20 years and draws on his dual ...

Lucid-MS, Quantum Biopharma's oral multiple sclerosis therapy candidate, was not toxic and had no side effects in healthy ...

A study found neurofilament light chain at high levels in the blood and CSF of MS patients, suggesting its potential as a ...

Switching from one CD20-targeting therapy to another doesn't alter their ability to lower disease activity and slow ...